Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 976 to 1000 of 1904

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Cabozantinib for treating medullary thyroid cancerTA516
Learning disabilities and behaviour that challenges: service design and deliveryNG93
Emergency and acute medical care in over 16s: service delivery and organisationNG94
Physical activity and the environmentNG90
Brodalumab for treating moderate to severe plaque psoriasisTA511
Tivozanib for treating advanced renal cell carcinomaTA512
Obinutuzumab for untreated advanced follicular lymphomaTA513
Mosaicplasty for symptomatic articular cartilage defects of the kneeIPG607
Laparoscopic mesh pectopexy for apical prolapse of the uterus or vaginaIPG608
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancerTA509
Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's diseaseIPG606
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
People's experience in adult social care services: improving the experience of care and support for people using adult social care servicesNG86
Aortic valve reconstruction with processed bovine pericardiumIPG604
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal womenTA160
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal womenTA161
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiencyHST7
Pancreatic cancer in adults: diagnosis and managementNG85
Pirfenidone for treating idiopathic pulmonary fibrosisTA504
Intrabeam radiotherapy system for adjuvant treatment of early breast cancerTA501
Ibrutinib for treating relapsed or refractory mantle cell lymphomaTA502
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancerTA503
Sore throat (acute): antimicrobial prescribingNG84
Lenvatinib with everolimus for previously treated advanced renal cell carcinomaTA498

Results per page

  1. 10
  2. 25
  3. 50
  4. All